Our Science
Nucleos(t)ides
Pipeline & Programs
Hepatitis C
Bemnifosbuvir + Ruzasvir
About Hepatitis C
About Atea
About Us
Leadership
Careers
Contact
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look Up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQS
Email Alerts
Contact IR
RSS Feeds
Contact Us
Get in touch.
For investor and media inquiries, please contact:
Jonae Barnes
Senior Vice President
Investor Relations & Corporate Communications
[email protected]
BREAKING NEWS
Atea Pharmaceuticals announces strategic collaboration with Roche to develop and commercialize AT-527 for patients with COVID-19.
Read More
Enter Site